Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Ранг среди акций #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Цена акции
$0.0001
Последняя синхронизация: 2023-05-22
Рыночная капитализация
$10.03K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля NuGenerex Immuno-Oncology, Inc. (NUGX)

Категория

История цены акций NuGenerex Immuno-Oncology, Inc. (NUGX)
Наивысшая цена закрытия: $0.00 2023-05-01

Наименьшая цена закрытия: $1.44 2021-03-01
История цены акций NuGenerex Immuno-Oncology, Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2023 75.00%
2022 -98.81%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.34%
KR